(Entertainment-NewsWire.com, August 23, 2018 ) Lactoferrin Market was worth USD 96.29 million in 2018, and is expected to grow at a CAGR of 8.3%, to reach USD 143.46 million by 2023.
Lactoferrin is a globular glycoprotein of the transferrin family. It is commonly present in several fluid secretions of humans such as milk, tears, saliva and nasal secretions. Human colostrum, first milk produced from mammary glands after child birth has highest concentration of lactoferrin. Human milk and cow milk follows colostrum respectively in terms of concentration.
Lactoferrin can be extracted or separated from milk or by using recombinant DNA modification techniques. Lactoferrin is involved in several biological activities such as antimicrobial activity especially in children, stimulation of immune cells and iron absorption. It also aids in bone formation and increase in anti-inflammatory responses of the body. Infants benefit highly from lactoferrin.
The numerous health benefits offered by lactoferrin protein in adults as well as infants have increased the demand for lactoferrin products. Factors such as rising prevalence of bacterial and viral infections, its prominent role in immune responses such as anti-inflammation and its ability to absorb iron are expected to drive the market. Advanced techniques to extract lactoferrin from skimmed milk resulting in increased production are also expected to propel the market. However, lack of awareness among people and high cost of products are inhibiting the market growth.
Based on geography, the market is categorized into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. Asia Pacific leads the global lactoferrin market due to the high birth rate resulting in high infant population. This in turn increased the demand for infant formula. Europe is expected to be the fastest growing market segment due to the favorable regulations regarding the use of lactoferrin in several products.
Some of the major players in this region are Glanbia Nutritionals, Westland Co-Operative Dairy Co. Ltd. Fonterra Co-Operative Group Ltd., MP Biomedicals, Synlait Milk Ltd., Ingredia SA, Vitalus Nutrition Inc., ProHealth and Metagenics.
